Articles by ‘Iain Butler’

RWK Goodman is pleased to have supported Oxfordshire-based Agrivert on the acquisition of Chiltern Solar Limited, a leading designer and installer of integrated solar PV, battery and EV charging solutions to domestic and commercial…

Law firm RWK Goodman has advised the shareholders of cloud-based vehicle diagnostic specialists SOMIT Solutions on its sale to KPIT Technologies. Based in Abingdon (Oxfordshire), SOMIT Solutions enables after-sales operations of high-tech luxury and…

Law firm RWK Goodman has advised investment company BGF on its investment as part of a multi-million-pound investment round for medical imaging company Caristo Diagnostics.

Law firm RWK Goodman has advised the shareholders and management team of data centre owner and operator Amito Ltd on its significant minority investment from Harwood Private Equity.

EBITDAC is the new acronym which has been much discussed recently as businesses and their advisers get to grips with how to adjust valuations to take into account the impact of Covid-19. Does this further increase uncertainty in an already unsettled M&A market and how much are we really going to see it used?

There has been a lot for private equity (PE) funders to deal with in the wake of the Covid-19 pandemic. Understandably short-term focus has been on supporting existing portfolio companies, but the expertise and resilience of PE funders (and their advisers) combined with a strong appetite to do deals means that PE-backed buy-outs and bolt-on acquisitions are likely to have a central role in the drive towards recovery.

RWK Goodman is pleased to announce that it’s helped Oxford Genetics (trading as OXGENE™), based at the Oxford Science Park, with a further £3.0m syndicated investment committed by Mercia Asset Management and Canaccord Genuity Wealth Management.

Testing is currently on top of the Government’s agenda in its efforts to slow down the coronavirus pandemic.

The spotlight is now very much on the UK’s life sciences sector and we’re very proud that our client Oxford Genetics (trading as OXGENE) has formed a strategic partnership with The Native Antigen Company Limited (NAC), another portfolio company backed by Mercia Asset Management, to scale up production of Covid-19 antigens to test for the disease.

Companies House have updated their policy so that if accounts are not able to be filed on time due to the company being affected by Coronavirus, the company may make an application before their deadline to extend the period allowed for filing. Upon application, the company will receive an automatic and immediate 3 month extension to file their accounts.

The issue of whether entrepreneurs’ relief (ER) will be scrapped in the Budget remains on the agenda, but you need to act now, says Iain Butler, a Corporate Partner in our Private Wealth team.

We are often used to hearing sayings like “the apple doesn’t fall far from the tree” or “like father like son/like mother like daughter”. These phrases are casually used to suggest that a child’s actions are not far off from the actions of their parent, or that a parent is wholly responsible for the behaviour of their child.

Corporate lawyers from RWK Goodman have helped Oxford Genetics, an Oxford based biotechnology business which specialises in biological drug development, to secure a £6.5m syndicated investment which will further secure its position as a market-leading innovator of synthetic biology-based technologies. The cash injection values Oxford Genetics, which is based at Oxford Science Park, at £30.5m.